Caerulomycin A

Overview

Caerulomycin A is an orally active immunomodulator and antimicrobial agent. Caerulomycin A targets Smad3 , STAT1 and GATA-3 . Caerulomycin A downregulates GATA-3 expression, inhibits Th2 cell differentiation and Th2 cytokine production, reduces IgE levels, and alleviates pulmonary inflammatory responses and eosinophil infiltration. Caerulomycin A ameliorates collagen-induced arthritis symptoms, reduces joint inflammation and synovitis, and decreases the levels of proinflammatory cytokines in joints. Caerulomycin A inhibits the growth of some filamentous fungi, yeasts and specific bacteria. Caerulomycin A can be used in research related to arthritis and asthma.

Application

Products | Products > Disease Areas > Respiratory Inflammation | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Fungal Infection | Products > Disease Areas > Asthma | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Lower Respiratory Inflammation | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Fungal | Products > Signaling Pathways > Antibiotic

Product Information

• Catalog No.: HY-114495
• CAS No.: 21802-37-9
• Molecular Formula: C12H11N3O2
• Molecular Weight: 229.24
• Purity: 98.0%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (10.91 mM); Clear solution
• Availability: In-stock

Source

Original product source